title: Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma.
abstract: Administration of tumor necrosis factor (TNF) and gamma interferon (IFN-gamma) to melanoma patients causes selective disruption of the tumor vasculature but the mechanism of this disruption is unknown. Here we report that exposure of human endothelial cells to TNF and IFN-gamma results in a reduced activation of integrin alphaVbeta3, an adhesion receptor that plays a key role in tumor angiogenesis, leading to a decreased alphaVbeta3-dependent endothelial cell adhesion and survival. Detachment and apoptosis of angiogenic endothelial cells was demonstrated in vivo in melanoma metastases of patients treated with TNF and IFN-gamma. These results implicate integrin alphaVbeta3 in the anti-vascular activity of TNF and IFN-gamma and demonstrate a new mechanism by which cytokines control cell adhesion.
authors.affiliation: Centre Pluridisciplinaire d'Oncologie, School of Medicine, University of Lausanne, Centre Hospitalier Universitaire Vaudois, Switzerland.
authors.forename: C
authors.initials: C
authors.lastname: Rüegg
authors.forename: A
authors.initials: A
authors.lastname: Yilmaz
authors.forename: G
authors.initials: G
authors.lastname: Bieler
authors.forename: J
authors.initials: J
authors.lastname: Bamat
authors.forename: P
authors.initials: P
authors.lastname: Chaubert
authors.forename: F J
authors.initials: FJ
authors.lastname: Lejeune
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D001706:Biopsy; D002448:Cell Adhesion / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology* / Q000627:therapeutic use; D008545:Melanoma / Q000098:blood supply* / Q000473:pathology / Q000628:therapy; D009362:Neoplasm Metastasis; D009389:Neovascularization, Pathologic / Q000523:psychology; D019030:Receptors, Vitronectin / Q000187:drug effects / Q000502:physiology*; D011994:Recombinant Proteins / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology* / Q000627:therapeutic use; D014471:Umbilical Veins
chemical_list: D019030:Receptors, Vitronectin; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma